Estimates Revisions Actinium Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
7AY1
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
07:05:45 28/09/2026 BST
|
Pre-market 06:05:02 | |||
| 1.024 EUR | +0.20% |
|
1.037 | +1.27% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Actinium Pharmaceuticals, Inc.(ATNM)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- ATNM Stock
- 7AY1 Stock
- Consensus Actinium Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
